News | January 12, 2011

SCAI Publishes Commentary on Future Cath Labs

January 12, 2011 – The Society for Cardiovascular Angiography and Interventions (SCAI) has published a paper on the future trends and developments in the cardiac catheterization laboratory and interventional vascular suite. The paper, titled "The Catheterization Laboratory and Interventional Vascular Suite of the Future: Anticipating Innovations in Design and Function," appears in the current issue of Catheterization and Cardiovascular Interventions.

It features predictions on the future of these medical spaces, including advances in technology and design as well as changes in function, staffing and economics. Specifically, it says that improvements and innovations will be stimulated by patients’ needs.

Advancements in medical technology accompanied by improved patient outcomes have led to an increase in the number of catheter-based therapies performed by clinicians. This trend is expected to continue with the discovery of novel techniques and superior medical technology. As science continues to guide medical advancement, the design and functionality of the cath lab and interventional vascular suite will likely continue to evolve. To achieve this, the paper recommends working with teams of physicians, scientists, regulators and manufacturers to create a functional suite for patients and staff.

"The future of the catheterization lab and interventional vascular suite is exciting to think about as we seek to continue improving patient care through minimally invasive techniques," said Lloyd Klein, M.D., FSCAI, professor of medicine at Rush Medical College and lead author of the paper. "As new therapies are pioneered we have the opportunity to collaborate and provide patients with state-of-the art facilities that ensure the highest quality of service and care, while offering a functional and safe medical environment for both patients and staff."

Medical advancements have also shifted trends in cardiac care, including a new case mix with fewer diagnostic catheterizations, earlier diagnosis of blocked arteries and increased use of combined (or hybrid) procedures. The number of structural heart disease patients treated with catheter-based treatments is likely to increase, as will patients treated for valvular disease.

According the paper, the future cath labs will likely include design and technology features such as:
• Robotic catheter manipulation directed by advanced imaging systems

• Miniaturization of therapeutic devices

• Integration of visual and other data from multiple sources, including the availability of archival solutions that are easily available and transferable to other medical professionals for consultation

• Advanced digital imaging, detailed 3-dimensional reconstruction and molecular imaging

• Utilization of virtual interfaces, trial procedures using virtual reality, and intelligent navigation during a procedure

• A dedicated information technology staff to manage ever-changing hardware, applications and monitoring programs that improve efficiency, eliminate disparate information and improve patient satisfaction

The paper also forecasts the future functionality of the cath lab, predicting two different interventional laboratory types. The first will be reminiscent of today's cath lab but will include greater diagnostic capability and improved patient comfort through decoration, lighting and diversions. The second will be a much larger alternative surgical suite equipped with large and complex imaging modalities and used for more complex procedures. This suite would be staffed and equipped to accommodate open surgery procedures, something not common in today's labs. Additionally, the lab design will minimize patient and staff radiation dose, allow for database consolidation and pooled learning, incorporate a sophisticated storage and inventory management system, and improve catheter navigation and device placement.

For more information: www.scai.org/asset.axd?id=5339d216-2efe-4a71-bee6-d602815eac4a&t=634302607018830000

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init